These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24131234)

  • 21. [The scope of prenatal diagnostic testing for chromosomal aberrations: broad or narrow? Ethical considerations on the choice of tests].
    de Jong A; Dondorp WJ; de Wert GM
    Ned Tijdschr Geneeskd; 2009; 153():A1060. PubMed ID: 20015413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological distress before and after prenatal invasive karyotyping.
    Cederholm M; Sjödén PO; Axelsson O
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):539-45. PubMed ID: 11380290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Full karyotyping, rapid aneuploidy diagnosis or both when invasive prenatal testing is performed for diagnosis of thalassaemia?
    Tse KY; Leung WC; Leung KY; Lee CP; Ng LK; Lau ET; Chan V; Tang MH
    Mol Hum Reprod; 2006 Jan; 12(1):55-9. PubMed ID: 16421217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening.
    Petersen OB; Vogel I; Ekelund C; Hyett J; Tabor A; ;
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):265-71. PubMed ID: 24375770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strong preference for non-invasive prenatal diagnosis in women pregnant through intracytoplasmic sperm injection (ICSI).
    Meschede D; Lemcke B; Stüssel J; Louwen F; Horst J
    Prenat Diagn; 1998 Jul; 18(7):700-5. PubMed ID: 9706651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid aneuploidy testing versus traditional karyotyping in amniocentesis for certain referral indications.
    Comas C; Echevarria M; Carrera M; Serra B
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):949-55. PubMed ID: 20718579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study.
    Bianchi DW; Simpson JL; Jackson LG; Elias S; Holzgreve W; Evans MI; Dukes KA; Sullivan LM; Klinger KW; Bischoff FZ; Hahn S; Johnson KL; Lewis D; Wapner RJ; de la Cruz F
    Prenat Diagn; 2002 Jul; 22(7):609-15. PubMed ID: 12124698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introducing array comparative genomic hybridization into routine prenatal diagnosis practice: a prospective study on over 1000 consecutive clinical cases.
    Fiorentino F; Caiazzo F; Napolitano S; Spizzichino L; Bono S; Sessa M; Nuccitelli A; Biricik A; Gordon A; Rizzo G; Baldi M
    Prenat Diagn; 2011 Dec; 31(13):1270-82. PubMed ID: 22034057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal diagnosis of trisomy 21: registration results from a single genetic center.
    Witters I; Fryns JP
    Genet Couns; 2008; 19(2):157-63. PubMed ID: 18618989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-trimester prenatal diagnosis performed on pregnant women with fetal ultrasound abnormalities: the reliability of interphase fluorescence in situ hybridization (FISH) on mesenchymal core for the main aneuploidies.
    Toutain J; Epiney M; Begorre M; Dessuant H; Vandenbossche F; Horovitz J; Saura R
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):143-6. PubMed ID: 20045588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of Detection Rates of Aneuploidy in High-Risk Pregnancy Using an Approach Based on Nuchal Translucency and Non-Invasive Prenatal Testing: A Cohort Study.
    Khalil A; Mahmoodian N; Kulkarni A; Homfray T; Papageorghiou A; Bhide A; Thilaganathan B
    Fetal Diagn Ther; 2015; 38(4):254-61. PubMed ID: 25925597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of non-detectable chromosomal abnormalities by QF-PCR in amniocentesis for certain referral indications: experience at a mainland Chinese hospital.
    Liao C; Yi CX; Li FT; Li DZ
    Arch Gynecol Obstet; 2014 Jan; 289(1):75-8. PubMed ID: 23836406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of indications and results of prenatal invasive diagnostic tests before and after the implementation of the use of cell-free fetal DNA: a tertiary referral center experience.
    Okmen F; Ekici H; Hortu I; Imamoglu M; Arican D; Akın H; Sagol S
    J Assist Reprod Genet; 2020 Aug; 37(8):2019-2024. PubMed ID: 32440934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is prenatal screening and why to do it?
    Temming LA; Macones GA
    Semin Perinatol; 2016 Feb; 40(1):3-11. PubMed ID: 26708051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive chromosome test raises new questions in prenatal diagnosis about the significance of ultrasound and questions about new screening strategies.
    Tercanli S; Vial Y; Merz E
    Ultraschall Med; 2013 Oct; 34(5):417-20. PubMed ID: 24127381
    [No Abstract]   [Full Text] [Related]  

  • 36. Access to prenatal cytogenetic diagnosis in Catania: a retrospective survey.
    Agodi A; Barchitta M; Quattrocchi A; Corallo T; Venticinque V; Caruso M
    Ann Ig; 2013; 25(6):529-37. PubMed ID: 24284539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of prenatal diagnosis in Cuba: causes of low prevalence of Down syndrome.
    Méndez-Rosado LA; Hechavarría-Estenoz D; de la Torre ME; Pimentel-Benitez H; Hernández-Gil J; Perez B; Barrios-Martínez A; Morales-Rodriguez E; Soriano-Torres M; Garcia M; Suarez-Mayedo U; Cedeño-Aparicio N; Blanco I; Díaz-Véliz P; Vidal-Hernández B; Mitjans-Torres M; Miñoso S; Alvarez-Espinosa D; Reyes-Hernández E; Angulo-Cebada E; Torres-Palacios M; Lozano-Lezcano L; Lima-Rodriguez U; Mayeta M; Noblet M; Benítez Y; Lardoeyt-Ferrer R; Yosela-Martin S; Carbonell P; Pérez-Ramos M; de León N; Perez M; Carbonell J
    Prenat Diagn; 2014 Nov; 34(11):1049-54. PubMed ID: 24861354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal screening of cytogenetic anomalies - a Western Indian experience.
    Sheth F; Rahman M; Liehr T; Desai M; Patel B; Modi C; Trivedi S; Sheth J
    BMC Pregnancy Childbirth; 2015 Apr; 15():90. PubMed ID: 25884925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
    Sharda S; Phadke SR
    J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic medicine in prenatal diagnosis.
    South ST; Chen Z; Brothman AR
    Clin Obstet Gynecol; 2008 Mar; 51(1):62-73. PubMed ID: 18303500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.